Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53,364,241
-
Total 13F shares
-
7,370,534
-
Share change
-
-112,615
-
Total reported value
-
$23,510,457
-
Price per share
-
$3.19
-
Number of holders
-
28
-
Value change
-
-$286,179
-
Number of buys
-
13
-
Number of sells
-
22
Institutional Holders of scPharmaceuticals Inc. - Common Stock (SCPH) as of Q2 2019
As of 30 Jun 2019 scPharmaceuticals Inc. - Common Stock (SCPH) had 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 7,370,534 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, LLC, Eversept Partners, LP, VANGUARD GROUP INC, NORTHERN TRUST CORP, BRIDGEWAY CAPITAL MANAGEMENT INC, Alambic Investment Management, L.P., RENAISSANCE TECHNOLOGIES LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, and MILLENNIUM MANAGEMENT LLC.
This table shows 28 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.